Combined effect of poverty and inflammation on mortality is worse than expected from separate effects, study reports

Researchers investigated whether the combination of chronic inflammation and poverty synergistically increases the 15-year risk of mortality from all causes, heart disease, and cancer in American adults aged 40 and older.

J&J Vision looks to the future with new corporate campaign spanning generations of eye health

From a baby’s first eye exam to aging peoples’ cataracts, J&J Vision’s newest corporate campaign navigates a lifetime of eye health through the lens of

September 29, 2023

No resolution on certain capital measures at the Annual General Meeting – Biotech Investments

aap Implantate AG / Key word(s): AGM/EGM/Corporate Action No resolution on certain capital measures at the Annual General Meeting 21-Jul-2023 / 18:54 CET/CEST Disclosure of

July 22, 2023

Eckert & Ziegler Subsidiary Pentixapharm Receives Encouraging FDA Feedback to Initiate Phase III Trial with PentixaFor as Radiopharmaceutical Diagnostic in Primary Aldosteronism – Biotech Investments

EQS-News: Eckert & Ziegler SE / Key word(s): Study Eckert & Ziegler Subsidiary Pentixapharm Receives Encouraging FDA Feedback to Initiate Phase III Trial with PentixaFor

June 26, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.